Test Code AMKRA Amikacin, Random, Serum
Reporting Name
Amikacin, Random, SPerforming Laboratory
Mayo Clinic Laboratories in RochesterUseful For
Monitoring adequacy of blood concentration during amikacin therapy
Ordering Guidance
Specimen for a peak level should be collected 30 to 60 minutes after last dose; order PAMIK / Amikacin, Peak, Serum.
Specimen for a trough level should be collected immediately before next scheduled dose; order TAMIK / Amikacin, Trough, Serum.
Specimen Required
Collection Container/Tube:
Preferred: Serum gel
Acceptable: Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 0.5 mL
Collection Instructions:
1. Serum gel tubes should be centrifuged within 2 hours of collection.
2. Red-top tubes should be centrifuged, and the serum aliquoted into a plastic vial within 2 hours of collection.
Specimen Minimum Volume
0.25 mL
Specimen Type
SerumSpecimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum | Refrigerated (preferred) | 14 days | |
Frozen | 28 days | ||
Ambient | 72 hours |
Day(s) Performed
Monday through Sunday
Reference Values
Peak: 20.0-35.0 mcg/mL
Toxic peak: >40.0 mcg/mL
Trough: <8.0 mcg/mL
Toxic trough:>10.0 mcg/mL
Method Name
Kinetic Interaction of Microparticles in Solution (KIMS)
Test Classification
This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
RAMIK | Amikacin, Random, S | 35669-1 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
RAMIK | Amikacin, Random, S | 35669-1 |
CPT Code Information
80150
Report Available
Same day/1 dayForms
If not ordering electronically, complete, print, and send a Therapeutics Test Request (T831) with the specimen.